Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury

Mark D Stegall, L. D. Cornell, W. D. Park, B. H. Smith, Fernando G Cosio

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Improving long-term renal allograft survival remains an important unmet need. To assess the extent of histologic injury at 10 years after transplantation in functioning grafts, we studied 575 consecutive adult solitary renal transplants performed between 2002 and 2005: 77% from living donors and 81% maintained on tacrolimus-based immunosuppression. Ten-year graft survival was 59% and death-censored graft survival was 74%. Surveillance allograft biopsies were assessed at implantation, 5 years, and 10 years from 145 patients who reached 10 years. At implantation, 5% of biopsies had major histologic abnormalities (chronic transplant glomerulopathy score > 0, other chronic Banff scores ≥ 2, global glomerulosclerosis > 20%, or mesangial sclerosis ≥ 2). This increased to 54% at 5 years and 82% at 10 years. Major lesions at 10 years included the following: arteriolar hyalinosis (66%), mesangial sclerosis (67%), and global glomerulosclerosis > 20% (43%), with 48% of grafts having more than one major lesion. Transplant glomerulopathy and moderate-to-severe interstitial fibrosis were uncommon (12% each). Major lesions were associated with increased proteinuria and decreased graft function. In patients with diabetes at baseline, 52% had diabetic nephropathy/mesangial sclerosis at 10 years. We conclude that almost all renal allografts sustain major histologic injury by 10 years after transplantation. Much damage appears nonimmunologic, suggesting that new approaches are needed to decrease late injury.

Original languageEnglish (US)
JournalAmerican Journal of Transplantation
DOIs
StateAccepted/In press - 2017

Fingerprint

Tacrolimus
Allografts
Histology
Transplantation
Transplants
Kidney
Wounds and Injuries
Sclerosis
Graft Survival
Biopsy
Living Donors
Diabetic Nephropathies
Proteinuria
Immunosuppression
Fibrosis

Keywords

  • Clinical research/practice
  • Interstitial fibrosis and tubular atrophy
  • Kidney (allograft) function/dysfunction
  • Kidney transplantation/nephrology
  • Pathology/histopathology
  • Protocol biopsy
  • Translational research/science

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era : Evidence of Pervasive Chronic Injury. / Stegall, Mark D; Cornell, L. D.; Park, W. D.; Smith, B. H.; Cosio, Fernando G.

In: American Journal of Transplantation, 2017.

Research output: Contribution to journalArticle

@article{b33e1a0cd4a740359eacdba29ff32e77,
title = "Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury",
abstract = "Improving long-term renal allograft survival remains an important unmet need. To assess the extent of histologic injury at 10 years after transplantation in functioning grafts, we studied 575 consecutive adult solitary renal transplants performed between 2002 and 2005: 77{\%} from living donors and 81{\%} maintained on tacrolimus-based immunosuppression. Ten-year graft survival was 59{\%} and death-censored graft survival was 74{\%}. Surveillance allograft biopsies were assessed at implantation, 5 years, and 10 years from 145 patients who reached 10 years. At implantation, 5{\%} of biopsies had major histologic abnormalities (chronic transplant glomerulopathy score > 0, other chronic Banff scores ≥ 2, global glomerulosclerosis > 20{\%}, or mesangial sclerosis ≥ 2). This increased to 54{\%} at 5 years and 82{\%} at 10 years. Major lesions at 10 years included the following: arteriolar hyalinosis (66{\%}), mesangial sclerosis (67{\%}), and global glomerulosclerosis > 20{\%} (43{\%}), with 48{\%} of grafts having more than one major lesion. Transplant glomerulopathy and moderate-to-severe interstitial fibrosis were uncommon (12{\%} each). Major lesions were associated with increased proteinuria and decreased graft function. In patients with diabetes at baseline, 52{\%} had diabetic nephropathy/mesangial sclerosis at 10 years. We conclude that almost all renal allografts sustain major histologic injury by 10 years after transplantation. Much damage appears nonimmunologic, suggesting that new approaches are needed to decrease late injury.",
keywords = "Clinical research/practice, Interstitial fibrosis and tubular atrophy, Kidney (allograft) function/dysfunction, Kidney transplantation/nephrology, Pathology/histopathology, Protocol biopsy, Translational research/science",
author = "Stegall, {Mark D} and Cornell, {L. D.} and Park, {W. D.} and Smith, {B. H.} and Cosio, {Fernando G}",
year = "2017",
doi = "10.1111/ajt.14431",
language = "English (US)",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era

T2 - Evidence of Pervasive Chronic Injury

AU - Stegall, Mark D

AU - Cornell, L. D.

AU - Park, W. D.

AU - Smith, B. H.

AU - Cosio, Fernando G

PY - 2017

Y1 - 2017

N2 - Improving long-term renal allograft survival remains an important unmet need. To assess the extent of histologic injury at 10 years after transplantation in functioning grafts, we studied 575 consecutive adult solitary renal transplants performed between 2002 and 2005: 77% from living donors and 81% maintained on tacrolimus-based immunosuppression. Ten-year graft survival was 59% and death-censored graft survival was 74%. Surveillance allograft biopsies were assessed at implantation, 5 years, and 10 years from 145 patients who reached 10 years. At implantation, 5% of biopsies had major histologic abnormalities (chronic transplant glomerulopathy score > 0, other chronic Banff scores ≥ 2, global glomerulosclerosis > 20%, or mesangial sclerosis ≥ 2). This increased to 54% at 5 years and 82% at 10 years. Major lesions at 10 years included the following: arteriolar hyalinosis (66%), mesangial sclerosis (67%), and global glomerulosclerosis > 20% (43%), with 48% of grafts having more than one major lesion. Transplant glomerulopathy and moderate-to-severe interstitial fibrosis were uncommon (12% each). Major lesions were associated with increased proteinuria and decreased graft function. In patients with diabetes at baseline, 52% had diabetic nephropathy/mesangial sclerosis at 10 years. We conclude that almost all renal allografts sustain major histologic injury by 10 years after transplantation. Much damage appears nonimmunologic, suggesting that new approaches are needed to decrease late injury.

AB - Improving long-term renal allograft survival remains an important unmet need. To assess the extent of histologic injury at 10 years after transplantation in functioning grafts, we studied 575 consecutive adult solitary renal transplants performed between 2002 and 2005: 77% from living donors and 81% maintained on tacrolimus-based immunosuppression. Ten-year graft survival was 59% and death-censored graft survival was 74%. Surveillance allograft biopsies were assessed at implantation, 5 years, and 10 years from 145 patients who reached 10 years. At implantation, 5% of biopsies had major histologic abnormalities (chronic transplant glomerulopathy score > 0, other chronic Banff scores ≥ 2, global glomerulosclerosis > 20%, or mesangial sclerosis ≥ 2). This increased to 54% at 5 years and 82% at 10 years. Major lesions at 10 years included the following: arteriolar hyalinosis (66%), mesangial sclerosis (67%), and global glomerulosclerosis > 20% (43%), with 48% of grafts having more than one major lesion. Transplant glomerulopathy and moderate-to-severe interstitial fibrosis were uncommon (12% each). Major lesions were associated with increased proteinuria and decreased graft function. In patients with diabetes at baseline, 52% had diabetic nephropathy/mesangial sclerosis at 10 years. We conclude that almost all renal allografts sustain major histologic injury by 10 years after transplantation. Much damage appears nonimmunologic, suggesting that new approaches are needed to decrease late injury.

KW - Clinical research/practice

KW - Interstitial fibrosis and tubular atrophy

KW - Kidney (allograft) function/dysfunction

KW - Kidney transplantation/nephrology

KW - Pathology/histopathology

KW - Protocol biopsy

KW - Translational research/science

UR - http://www.scopus.com/inward/record.url?scp=85027522509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027522509&partnerID=8YFLogxK

U2 - 10.1111/ajt.14431

DO - 10.1111/ajt.14431

M3 - Article

C2 - 28710896

AN - SCOPUS:85027522509

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

ER -